Big Data represents the vast and continuously growing amount of health information and its usage to drive innovation in translational research and health outcomes tailored to the individual.
Using these data to first understand the cause of disease, the medical profession can then develop new drugs and therapies to find the cure, as well as other health interventions targeting the individual.
The area of personalised medicine has grown rapidly over the last decade due to improvements in areas such as genomic sequencing, diagnostic testing etc.
This has allowed us to gain a deep mechanistic understanding of a disease, meaning that patients can now be sorted into groups who are likely to benefit from a specific treatment.
The personalised, individual approach requires advanced technologies and processes to collect, manage and analyse the information and, even more importantly, to contextualise it, integrate it, interpret it and provide rapid and precise decision support in a clinical and public health context. A focus on personalised medicine would be extremely beneficial to Europe.